Alvin I Mushlin
Overview
Explore the profile of Alvin I Mushlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu J, Kim K, Yu H, Gupta A, Mushlin A, Kamel H, et al.
JAMA Neurol
. 2025 Jan;
82(3):307-308.
PMID: 39804662
No abstract available.
2.
Charalel R, Mushlin A, Zheng X, Mao J, Carlos R, Brown Jr R, et al.
AJR Am J Roentgenol
. 2024 Jun;
223(2):e2431272.
PMID: 38899842
Differences in survival and morbidity among treatment options (ablation, surgical resection, and transplant) for early-stage hepatocellular carcinoma (HCC) have been well studied. Additional understanding of the costs of such care...
3.
Cost-Effectiveness of Screening Asymptomatic Carotid Stenosis by Atherosclerotic Cardiovascular Risk
Zhu J, Jhang J, Yu H, Mushlin A, Kamel H, Alemayehu N, et al.
medRxiv
. 2024 May;
PMID: 38798437
Importance: Extracranial internal carotid artery stenosis (50-99% arterial narrowing) is an important risk factor for ischemic stroke. Yet, the benefits and harms of targeted screening for asymptomatic carotid artery stenosis...
4.
Charalel R, Mushlin A, Mao J, Fortune B, Madoff D, Johnson M, et al.
J Am Coll Radiol
. 2024 May;
21(9):1331-1332.
PMID: 38719105
No abstract available.
5.
Flory J, Zhang Y, Banerjee S, Wang F, Min J, Mushlin A
J Eval Clin Pract
. 2024 May;
30(4):716-725.
PMID: 38696462
Background And Objectives: Use of algorithms to identify patients with high data-continuity in electronic health records (EHRs) may increase study validity. Practical experience with this approach remains limited. Methods: We...
6.
Charalel R, Mushlin A, Zheng X, Mao J, Carlos R, Brown Jr R, et al.
J Am Coll Radiol
. 2023 Nov;
21(2):295-308.
PMID: 37922972
Objective: To identify independent predictors of all-cause and cancer-specific mortality after ablation or surgical resection (SR) for small hepatocellular carcinomas (HCCs), after adjusting for key confounders. Methods: Using Surveillance, Epidemiology,...
7.
Charalel R, Mushlin A, Zheng X, Mao J, Carlos R, Brown Jr R, et al.
J Vasc Interv Radiol
. 2023 Jul;
34(11):1997-2005.e3.
PMID: 37468093
Purpose: To compare secondary outcomes after ablation (AB), surgical resection (SR), and liver transplant (LT) for small hepatocellular carcinomas (HCCs), including resource utilization and adverse event (AE) rates. Materials And...
8.
Zhu J, Kamel H, Gupta A, Mushlin A, Menzies N, Gaziano T, et al.
Ann Intern Med
. 2023 May;
176(5):649-657.
PMID: 37126821
Background: The American Heart Association and American Stroke Association (AHA/ASA) endorsed 15 process measures for acute ischemic stroke (AIS) to improve the quality of care. Identifying the highest-value measures could...
9.
Charalel R, Mushlin A, Li D, Mao J, Ibrahim S, Carlos R, et al.
J Am Coll Radiol
. 2022 Oct;
19(11):1213-1223.
PMID: 36208842
Objective: To compare survival outcomes (all-cause, cancer-specific, and disease-free) for small hepatocellular carcinomas (HCCs), less than or equal to 5 cm, after ablation (AB) and surgical resection (SR) after adjusting...
10.
Min J, Simmons W, Banerjee S, Wang F, Williams N, Zhang Y, et al.
Diabetes Obes Metab
. 2022 Apr;
24(7):1402-1405.
PMID: 35373892
No abstract available.